Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
1.250
0.00 (0.00%)
Mar 25, 2025, 4:00 PM EST - Market closed
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $3.38 million as of March 26, 2025. Its market cap has decreased by -55.54% in one year.
Market Cap
3.38M
Enterprise Value
-3.54M
1-Year Change
-55.54%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $3.38M, a decrease of -94.82%. That is a compound annual growth rate of -56.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2025 | 1.58M | -60.32% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 776.33B |
| UnitedHealth Group | 471.95B |
| Johnson & Johnson | 393.36B |
| AbbVie | 369.24B |
| Novo Nordisk | 335.17B |
| Merck & Co. | 233.13B |
| AstraZeneca | 229.25B |
| Abbott Laboratories | 220.59B |